Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
The design of immunogens that elicit broadly reactive neutralizing antibodies (bnAbs) has been a major obstacle to HIV-1 vaccine development. One approach to assess potential immunogens is to use mice expressing precursors of human bnAbs as vaccination models. The bnAbs of the VRC01-class derive fro...
Saved in:
Published in: | Cell Vol. 166; no. 6; pp. 1471 - 1484.e18 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
08-09-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The design of immunogens that elicit broadly reactive neutralizing antibodies (bnAbs) has been a major obstacle to HIV-1 vaccine development. One approach to assess potential immunogens is to use mice expressing precursors of human bnAbs as vaccination models. The bnAbs of the VRC01-class derive from the IGHV1-2 immunoglobulin heavy chain and neutralize a wide spectrum of HIV-1 strains via targeting the CD4 binding site of the envelope glycoprotein gp120. We now describe a mouse vaccination model that allows a germline human IGHV1-2∗02 segment to undergo normal V(D)J recombination and, thereby, leads to the generation of peripheral B cells that express a highly diverse repertoire of VRC01-related receptors. When sequentially immunized with modified gp120 glycoproteins designed to engage VRC01 germline and intermediate antibodies, IGHV1-2∗02-rearranging mice, which also express a VRC01-antibody precursor light chain, can support the affinity maturation of VRC01 precursor antibodies into HIV-neutralizing antibody lineages.
[Display omitted]
•Mice generate diverse primary B cell receptors from a single human VH segment•An efficient new method generated mouse models for assessing human vaccination strategies•Step-wise immunization induced affinity maturation of HIV-neutralizing antibodies in mice
Sequential immunization using modified HIV envelope glycoproteins supports the maturation of HIV-neutralizing antibody lineages in mouse models that have diverse antibody repertoire and therefore are closer to physiological immunization settings than conventional transgenic models. |
---|---|
Bibliography: | Lead Contact: Frederick W. Alt Equal Contribution |
ISSN: | 0092-8674 1097-4172 |
DOI: | 10.1016/j.cell.2016.07.029 |